Inventor · disambiguated record
Charles Glabe
Also filed as: GLABE CHARLES · GLABE CHARLES G
7 granted patents·6 pending applications·66 citations·filing 1998–2017
84Inventor score
Top patents by PatentIndex Score
13 records- 0187US9535076B2Methods and compositions for eliciting an amyloid-selective immune responseKAYED RAKEZ·Filed 2009·Granted Jan 3, 2017·16 cites·12 claims
- 0286US9229009B2Methods and kits for detecting misfolded proteinsBUHIMSCHI CATALIN S·Filed 2009·Granted Jan 5, 2016·10 cites·11 claims
- 0383US11125758B2Methods and kits for detecting misfolded proteinsUNIV YALE·Filed 2017·Granted Sep 21, 2021·1 cites·10 claims
- 0474US8871447B2Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequenceKAYED RAKEZ·Filed 2003·Granted Oct 28, 2014·10 cites·19 claims
- 0565US6770448B2Fluorescent amyloid Aβ peptides and uses thereofUNIV CALIFORNIA·Filed 2003·Granted Aug 3, 2004·6 cites·14 claims
- 0660US6600017B1Fluorescent amyloid Aβ peptides and uses thereofUNIV CALIFORNIA·Filed 1998·Granted Jul 29, 2003·23 cites·15 claims
- 0757US2004224365A1Fluorescent amyloid Abeta peptides and uses thereofFiled 2004·Application pending·0 cites
- 0849US2011200609A1Monoclonal antibodies specific for pathological amyloid aggregates common to amyloids formed from proteins of differing sequenceUNIV CALIFORNIA·Filed 2009·Application pending·0 cites
- 0945US2007110750A1Monoclonal antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequenceUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 1044US9989540B2Diagnostic and monitoring system for Huntington's diseaseUNIV CALIFORNIA·Filed 2014·Granted Jun 5, 2018·0 cites·17 claims
- 1143US2015297674A1Substances and methods for the treatment of cerebral amyloid angiopathy related conditions or diseaseUNIV LOMA LINDA MED·Filed 2013·Application pending·0 cites
- 1234US2015353623A1Substances and methods for the treatment of cerebral amyloid angiopathy related conditions or diseasesUNIV LOMA LINDA·Filed 2015·Application pending·0 cites
- 1333US2011020237A1Compositions and Methods for Inhibiting Drusen Formation and for Diagnosing or Treating Drusen-Related DisordersGLABE CHARLES G·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →